Search

Your search keyword '"Slabbynck, Hans"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Slabbynck, Hans" Remove constraint Author: "Slabbynck, Hans" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
44 results on '"Slabbynck, Hans"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis Registry.

5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

6. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

7. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry

8. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.

9. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry.

10. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

11. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

12. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

16. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

17. MOESM1 of Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo â a post-hoc analysis of the BACE randomized controlled trial

18. MOESM1 of Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

19. Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial

20. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - A post-hoc analysis of the BACE randomized controlled trial

21. Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial.

22. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry

24. Diagnostic ability of a dynamic multidisciplinary discussion in Interstitial Lung Diseases: a retrospective observational study of 938 cases

27. Overuse of inhaled corticosteroids in COPD: Five questions for withdrawal in daily practice

28. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.

29. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: The PROOF registry

30. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

31. Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

34. Dyspnea in homosexual male patients: throwback to an occasionally forgotten but severe clinical presentation of HIV/AIDS

35. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: An investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

36. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

37. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

38. A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting.

39. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis.

41. Macromolecular creatine kinase type 1: A serum marker associated with disease

42. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

43. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.

44. Predominant dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: to be distinguished from idiopathic pulmonary fibrosis.

Catalog

Books, media, physical & digital resources